Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Global Cancer Diagnostics Market 2013 France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares, Competitive Strategies
US$ 26,000.00
... alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological ... specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer ...
August 2013
1200 pages
Competitor Analysis: Anaplastic Lymphoma Kinase (ALK) Inhibitors
US$ 199.00
The present Competitive Intelligence report about Anaplastic Lymphoma Kinase (ALK) Inhibitors provides a competitor evaluation in the field of small molecule and antibody-based inhibitors of Anaplastic Lymphoma Kinase (ALK) for the treatment of solid tumors as of August 2013. Purchase ...
August 2013
17 pages
Competitor Analysis: Poly-Adenyl-Ribose Polymerase (PARP) Inhibitors
US$ 199.00
The present Competitive Intelligence report about Poly-Adenyl-Ribose Polymerase (PARP) Inhibitors provides a competitor evaluation in the field of small molecule ... that repair DNA damage. Despite the recent failure of Sanofi’s PARP inhibitor iniparib, presentation of results from clinical studies with other ...
August 2013
22 pages
Ovarian Cancer Pipeline Analysis
US$ 1,800.00
... when purchasing Hard Copy License depending on the location. “Ovarian Cancer Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... reader to identify and understand the therapeutics associated with the Ovarian Cancer disease. The information for particular drug in development process ...
August 2013
660 pages
Pancreatic Cancer Drug Pipeline Analysis
US$ 1,800.00
... purchasing Hard Copy License depending on the location. “Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various ... . Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, ...
August 2013
515 pages
World Cancer Diagnostic Testing Market: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities
US$ 26,000.00
... and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers. The report is available by region, country, section, market segment and individual test: Regions: Global, Europe Countries: France, Germany, Italy ...
July 2013
-
Cancer Monoclonal Antibodies Market Forecast to 2017
US$ 1,500.00
... in the pipeline. According to RNCOS' report, "Cancer Monoclonal Antibodies Market Forecast to 2017", the market for cancer mAbs is estimated at US$ 24 Billion, and ... approval of these drugs will drive a major change in the market in terms of market share of current drugs. Finally, RNCOS concludes its report ...
July 2013
105 pages
Tumor Markers: Granular Analysis of the Global Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests France, Germany, Italy, Japan, Spain, UK, US
US$ 16,880.00
... contains 450 tables from Venture Planning Group’s new 7-country study, “Tumor Markers: US, Europe, Japan,” including supplier shares, as well as test volume ... Japan Spain UK USA Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker and country. Five-year ...
July 2013
-
Cancer Generics Market Outlook 2017
US$ 1,000.00
... growth. According to our latest research report “Cancer Generics Market Outlook 2017”, this market for cancer generics is expected to grow at 13%, reaching US$ 19 Billion ... oral and injectable options, encompassing all the recently approved generics along with existing ones. The detailed study of each drug ...
June 2013
95 pages
Cancer Diagnostic Testing: Granular Analysis of the Global Market Supplier Shares and Forecasts for Current and Emerging Tumor Markers France, Germany, Italy, Japan, Spain, UK, US
US$ 16,880.00
... new 7-country study, “Competing in the Global Cancer Diagnostics Market,” including supplier shares, as well as test volume and sales forecasts for 40 ... Coverage France Germany Italy Japan Spain UK USA Market Segmentation Analysis Sales and market shares of major suppliers, by individual tumor marker ...
June 2013
450 pages
Breast Cancer Market Report: 2013 Edition
US$ 800.00
... ‘malignant’ (potentially dangerous). ‘Breast cancer’ is a malignant tumor that has developed from cells in the breast. Typically breast cancer either begins in the cells ... over. The present report offers a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions ...
May 2013
55 pages
Tumor Markers in Europe: Market Segment Forecasts and Supplier Shares
US$ 15,760.00
... and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, ... diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and ...
May 2013
820 pages
UK Tumor Marker Testing Market Innovations, Trends and Opportunities for Suppliers
US$ 4,880.00
... shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
May 2013
575 pages
US Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers
US$ 7,760.00
... shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as ... , lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for ...
May 2013
620 pages
2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan
US$ 6,800.00
... Hemoglobin HCG 25-Hydroxy Vitamin D2 and D3 Occult Blood PAP PSA Thyroglobulin Vitamin B-12 During the next decade, the tumor markers and ... as specimen preparation devices, controls, calibrators and others. “2013 Tumor Markers and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, ...
May 2013
320 pages
CompetitiveWatch Cancer Diagnostics: Strategic Assessments of Major Suppliers
US$ 2,000.00
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages
May 2013
80 pages
2013 Analysis of the French Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
585 pages
2013 Analysis of the Italian Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
570 pages
2013 Analysis of the German Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
585 pages
2013 Analysis of the Japanese Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 6,000.00
Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $2,450. Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
590 pages
2013 Analysis of the Spanish Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and ...
April 2013
565 pages
2013 Analysis of the UK Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
April 2013
575 pages
2013 Analysis of the US Tumor Marker Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 7,760.00
Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
April 2013
620 pages
2013 Analysis of the French Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
585 pages
2013 Analysis of the German Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
585 pages
2013 Analysis of the Italian Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
570 pages
2013 Analysis of the Japanese Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 6,080.00
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
April 2013
590 pages
2013 Analysis of the Spanish Cancer Diagnostics Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, and Competitive Landscape
US$ 4,880.00
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2013
565 pages